Personalized Nutrition Market (By Product: Active Measurement, Standard Measurement; By Application: Standard Supplement, Disease-based; By End use: Direct-to-consumer, Wellness & Fitness Centers, Hospital & Clinics, Institutions, Food Delivery Services; By Dosage Forms: Tablets, Capsule, Powders, Liquids, Others; By Disease) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global personalized nutrition market size was valued at USD 11.80 billion in 2022 and it is projected to be worth around USD 48.78 billion by 2032, registering at a compound annual growth rate (CAGR) of 15.30% during the forecast period 2023 to 2032.
Nutrition is the study of how food and diet affects the body. Nutrition plays an important part in our life. It helps in improving our physical and mental performance by optimizing it to our needs and desires. Personalized nutrition is analyzing how food and genes interact with each other to create a personalized diet which compliments a person’s individual need.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
Key Takeaways:
Growth Factors
Report Scope of the Personalized Nutrition Market
Report Coverage | Details |
Market Size by 2032 | USD 48.78 Billion |
Growth Rate from 2023 to 2032 |
CAGR of 15.30% |
Largest Market Share in 2022 | North America |
Fastest Growing Region | Asia Pacific |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Product, Application, End use, Dosage Forms, Disease, Geography |
Companies Mentioned | DNA Fit, Superior Supplement Manufacturing, Metagenetics, Inc., Asiamerica, Ingredients, Nutralliance, Inc., Mixfix, Inc., Barrington Nutritionals, Balchem Corporation, Arizona Nutritional Supplements, Maat Nutritionals, Natures Product Inc. |
Application Insights
Genetic based personalization
Nutritional genomics, or nutrigenomics, is the study of how genes and nutrients interact at the cellular level to determine an individual's outcome. We now know that, depending on their genetic makeup, different people digest the same nutrients in various ways. Individual responses to grain, cholesterol, and even caffeine, for example, differ. Nutrients have also been shown to interact with our genomes and alter gene expression. Obese people, for example, had their metabolic genes expressed differently when they changed their diet carbohydrate intake, resulting in weight loss. Nutrients have also been shown to have an impact on epigenetic consequences, or how genes are expressed without modifying the DNA. This type of services allows consumers to get a saliva swab to assess their genetic information related to health. Services differ for personalization of diet from person to person based on their DNA. Furthermore, corporations are rapidly disseminating genetic direct-to-consumer (DTC) tests. Scientific organizations have stated unequivocally that genetic DTC tests have no scientific backing. Gene-based tailored diet has not yet been proven to be effective in the treatment of obesity. Personalized dietary recommendations based on a person's genetic profile, on the other hand, are a novel and promising approach to obesity prevention and treatment.
Evaluation type of service is the fastest growing personalization nutrition category. Diet and nutrition apps are among the most popular health and fitness applications, with a growing number of people using them on their mobile devices. The product labels are read by the analyzed app. The system then evaluates the quality of components and nutritional values based on the user’s personal information, such as age and degree of physical activity, and suggest healthier food options. The scientific proof of nutrition information applications' effectiveness in influencing consumers' healthy eating habits is currently lacking. This is especially obvious among customers who are increasing their motivation and planning actual activities to promote healthy eating. Using a nutrition-information app, in particular, reduces the sense of barriers to consuming healthful foods. When it comes to approaching healthy eating, users have a better perception of personal strength and self-confidence. The app users' objective and subjective knowledge of healthful foods improved.
In Micrbiome type of services consumer are asked to provide their stool sample to analyze the presence of microbial DNA. This helps in analyzing the gut health to give an indication of micro-organism distribution in gut to give a proper health/diet plan based on it. More recently researchers have begun looking into the link between gut micro biota health and diseases like Alzheimer's, Parkinson's, and depression. More than 1000 kinds of bacteria and other microbes make up the gut micro biome, the body's least well-known organ. It generates hormones, digests food that the stomach can't, and sends thousands of different diet-derived compounds flowing through our systems every day, weighing almost a pound. In many ways, the micro biome is critical to understanding nutrition and provides the foundation for Personalized nutrition's growth. Despite the fact that each of us is born with a unique micro biome, a variety of factors such as mode of birth, genetic makeup, nutrition, age, and antibiotics all have a role in reshaping the micro biome population. The gut microorganisms also manufacture vitamins and other substances that humans are unable to produce, allowing us to identify which nutrients are available from the food we eat
There are many devices available which analyze the hydrogen level in a person’s breath and provide suggestions for improving the same. Carbohydrate malabsorption is a common digestive issue that causes stomach pain, bloating, and diarrhoea. The most reliable and validated diagnostic approach is hydrogen breath testing (BT). The purpose of this paper was to explain how beneficial BTs can be in the nutritional therapy of various illnesses. Brands such as the Germany’s Baze and UK’s Vitl monitor blood levels of common micronutrients, such as foliate, iron, vitamin B12 and vitamin D to recommend monthly, vitamins, mineral and supplement packs. Clinical biomarkers are objective reflections of an individual's health and illness status, whereas nutritional biomarkers are objective reflections of an individual's dietary intake. Dietary consumption may or may not be reflected in clinical biomarkers. Many earlier association studies revealed a relationship between a specific biomarker and a specific food. A biomarker, on the other hand, may not necessarily indicate a single nutrient. It could be a reflection of a dietary pattern as a whole, or an interaction of many nutrients. The same is true for clinical biomarkers, which can signal a variety of health indices or metabolic processes with a single biomarker.
Disease Type Insights
The disease based segment is expected to hit at USD 11,930 million by 2032 from valued at USD 4,503 million in 2022.
Disease type takes into account medical history of the consumer and helps to create a diet and supplement plan according to their needs. There are foods that can elevate symptoms of certain health conditions and certain foods that can exacerbate them. Precision medicine focuses on improving the treatment of any illness by adapting it to the individual, while precision nutrition focuses on food intake. Both create therapies based on a person's unique traits, such as DNA, race, gender, health history, and lifestyle choices, to prevent or treat chronic diseases. Both aim to deliver more specific and targeted techniques for disease prevention and treatment, making them safer and more successful. Precision nutrition recognizes that each person's susceptibility to different foods and nutrients is different, so one person's best diet can be very different from another.
It has also been customized according to the need of the consumers. Healthy eating has become fashionable, to the point that, in the age of the internet and apps, there is an extraordinary profusion of services and tools available to assist those who wish to eat properly and stay in shape. Perhaps you should follow a tailored diet based on your physical attributes, as well as any health issues or dietary intolerance you may have. This type of app can assist you in determining the best foods to eat for your overall health. Different dietary programme are required for different compositions. Some people thrive on a high-protein diet, while others require a higher carbohydrate intake.
Not eating right food can be detrimental to your health. Several smartphone apps exist that can track food, count calories, and plan meals, similar to the tracking devices.
One of the biggest benefits of customizing your nutrition is that it can help you meet your specific health needs.
It's a scientifically proven essence that offers a wide range of benefits, whether you're looking to sleep better, lose weight, reduce stress, or improve your overall well-being. The COVID-19 epidemic prompted a shift in consumer behaviour, with more people choosing virtual fitness over traditional clubs. Due to lockdown constraints, the COVID-19 epidemic is creating expansion prospects for workout applications, resulting in widespread adoption of fitness apps for body weight training.
KEY MARKET DEVELOPMENTS
The rising need for customized solutions as a result of increased health awareness, the expanding trend of digital healthcare solutions, and the ageing population across regions are all expected to contribute to the market's growth over the forecast period. In addition, changing consumer trends, such as an increase in the choice for high-quality nutritional food based on their nutrient profile, are expected to drive the development of customized nutrition techniques, boosting market growth. According to studies, the most popular reasons for implementing individualized nutrition program, products, and strategies are:
Key Players
Market Segmentation
(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)
By Product
By Application
By End use
By Dosage Forms
By Disease
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Personalized Nutrition Market
5.1. COVID-19 Landscape: Personalized Nutrition Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Personalized Nutrition Market, By Product
8.1. Personalized Nutrition Market, by Product, 2023-2032
8.1.1. Active Measurement
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Standard Measurement
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Personalized Nutrition Market, By Application
9.1. Personalized Nutrition Market, by Application, 2023-2032
9.1.1. Standard Supplement
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Disease-based
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Personalized Nutrition Market, By End use
10.1. Personalized Nutrition Market, by End use, 2023-2032
10.1.1. Direct-to-consumer
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Wellness & Fitness Centers
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Hospital & Clinics
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Institutions
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Food Delivery Services
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Personalized Nutrition Market, By Dosage Forms
11.1. Personalized Nutrition Market, by Dosage Forms, 2023-2032
11.1.1. Tablets
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Capsule
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Powders
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Liquids
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Personalized Nutrition Market, By Disease
12.1. Personalized Nutrition Market, by Disease, 2023-2032
12.1.1. Customized to the needs of consumer
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Fitness Goal Oriented Application
12.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Personalized Nutrition Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.2. Market Revenue and Forecast, by Application (2020-2032)
13.1.3. Market Revenue and Forecast, by End use (2020-2032)
13.1.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.1.5. Market Revenue and Forecast, by Disease (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Application (2020-2032)
13.1.6.3. Market Revenue and Forecast, by End use (2020-2032)
13.1.6.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.1.7. Market Revenue and Forecast, by Disease (2020-2032)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.8.2. Market Revenue and Forecast, by Application (2020-2032)
13.1.8.3. Market Revenue and Forecast, by End use (2020-2032)
13.1.8.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.1.8.5. Market Revenue and Forecast, by Disease (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.2. Market Revenue and Forecast, by Application (2020-2032)
13.2.3. Market Revenue and Forecast, by End use (2020-2032)
13.2.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.2.5. Market Revenue and Forecast, by Disease (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
13.2.6.3. Market Revenue and Forecast, by End use (2020-2032)
13.2.7. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.2.8. Market Revenue and Forecast, by Disease (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Application (2020-2032)
13.2.9.3. Market Revenue and Forecast, by End use (2020-2032)
13.2.10. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.2.11. Market Revenue and Forecast, by Disease (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Application (2020-2032)
13.2.12.3. Market Revenue and Forecast, by End use (2020-2032)
13.2.12.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.2.13. Market Revenue and Forecast, by Disease (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Application (2020-2032)
13.2.14.3. Market Revenue and Forecast, by End use (2020-2032)
13.2.14.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.2.15. Market Revenue and Forecast, by Disease (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.2. Market Revenue and Forecast, by Application (2020-2032)
13.3.3. Market Revenue and Forecast, by End use (2020-2032)
13.3.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.3.5. Market Revenue and Forecast, by Disease (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
13.3.6.3. Market Revenue and Forecast, by End use (2020-2032)
13.3.6.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.3.7. Market Revenue and Forecast, by Disease (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Application (2020-2032)
13.3.8.3. Market Revenue and Forecast, by End use (2020-2032)
13.3.8.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.3.9. Market Revenue and Forecast, by Disease (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Application (2020-2032)
13.3.10.3. Market Revenue and Forecast, by End use (2020-2032)
13.3.10.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.3.10.5. Market Revenue and Forecast, by Disease (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Application (2020-2032)
13.3.11.3. Market Revenue and Forecast, by End use (2020-2032)
13.3.11.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.3.11.5. Market Revenue and Forecast, by Disease (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.2. Market Revenue and Forecast, by Application (2020-2032)
13.4.3. Market Revenue and Forecast, by End use (2020-2032)
13.4.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.4.5. Market Revenue and Forecast, by Disease (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
13.4.6.3. Market Revenue and Forecast, by End use (2020-2032)
13.4.6.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.4.7. Market Revenue and Forecast, by Disease (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Application (2020-2032)
13.4.8.3. Market Revenue and Forecast, by End use (2020-2032)
13.4.8.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.4.9. Market Revenue and Forecast, by Disease (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Application (2020-2032)
13.4.10.3. Market Revenue and Forecast, by End use (2020-2032)
13.4.10.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.4.10.5. Market Revenue and Forecast, by Disease (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Application (2020-2032)
13.4.11.3. Market Revenue and Forecast, by End use (2020-2032)
13.4.11.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.4.11.5. Market Revenue and Forecast, by Disease (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.2. Market Revenue and Forecast, by Application (2020-2032)
13.5.3. Market Revenue and Forecast, by End use (2020-2032)
13.5.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.5.5. Market Revenue and Forecast, by Disease (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Application (2020-2032)
13.5.6.3. Market Revenue and Forecast, by End use (2020-2032)
13.5.6.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.5.7. Market Revenue and Forecast, by Disease (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Application (2020-2032)
13.5.8.3. Market Revenue and Forecast, by End use (2020-2032)
13.5.8.4. Market Revenue and Forecast, by Dosage Forms (2020-2032)
13.5.8.5. Market Revenue and Forecast, by Disease (2020-2032)
Chapter 14. Company Profiles
14.1. DNA Fit
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Superior Supplement Manufacturing
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Metagenetics, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Asiamerica, Ingredients
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Nutralliance, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Mixfix, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Barrington Nutritionals
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Balchem Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Arizona Nutritional Supplements
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Maat Nutritionals
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client